AI in drug discovery adoption barriers in developed countries worldwide 2023
According to a survey from 2023, the availability of sufficient/high quality data was the most often stated barrier to the adoption of artificial intelligence (AI) in drug discovery in high-income countries. Other frequently named barriers included the availability of suitable staff and the lack of understanding of AI. This statistic shows the leading barriers for AI adoption in drug discovery in developed countries.